Catalyst funding for pump-priming projects is available to support collaborations between Network members in bacterial vaccinology to explore new approaches and strategies to advance their vaccines in partnership with LMICs and industry, and acquire the data to support substantive funding applications.
BactiVac aims to fund a diversified portfolio of projects to catalyse research in bacterial vaccinology.
Applications should be made using the application form available on the website. Projects will need to
align to one of the following (you will need to indicate which of these apply within your application):
1. Projects that focus on pathogens with outbreak potential
2. Projects that advance the ability to tackle the global challenge of antimicrobial resistance (AMR)
through the development of vaccines to bacterial pathogens.
In addition to the points raised above, projects will be prioritised against the following criteria (equally
weighted):
• Projects that target the exploratory to pre-clinical and clinical transitional bottlenecks
• The generation of novel partnerships between UK and LMIC partners (applications where the
lead applicant is LMIC based are strongly encouraged in this round of catalystfunding)
• The generation of novel partnerships between UK and industry partners
• Projects that involve partnerships between diverse Network members, particularly those that
include partners from LMICs and industry
• Projects that demonstrate a clear plan as to how the partnership will grow and be competitive
for further funding – EXCEPTIONALLY, well-defined short-term projects will beconsidered
• Projects that demonstrate that research governance is already in place (e.g. collaboration
agreements / intellectual property (IP) considerations). BactiVac aims to fund a diversified
portfolio of projects which catalyse research in bacterial vaccinology
Sponsor Institute/Organizations: University of Birmingham
Sponsor Type:
Address: University of Birmingham, Edgbaston Birmingham, B15 2TT United Kingdom
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jun 15, 2025
Jun 15, 2025
$129,380
Affiliation: University of Birmingham
Address: University of Birmingham, Edgbaston Birmingham, B15 2TT United Kingdom
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.